• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases.
Market Cap | 68.615 Million | Shares Outstanding | 22.35 Million | Avg 30-day Volume | 40.263 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -6.36 |
Price to Revenue | 621.213 | Debt to Equity | 0.0 | EBITDA | -204.408 Million |
Price to Book Value | 4.9291 | Operating Margin | -3683.0105000000003 | Enterprise Value | 2.913 Billion |
Current Ratio | 25.933 | EPS Growth | -0.582 | Quick Ratio | 25.545 |
1 Yr BETA | 0.0757 | 52-week High/Low | 0.0 / | Profit Margin | -3700.0686 |
Operating Cash Flow Growth | -77.9667 | Free Cash Flow to Firm (FCFF) TTM | -149.072 Million | Free Cash Flow to Equity (FCFE) TTM | -165.679 Million |
Altman Z-Score | 64.2992 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
No longer subject to file | 2015-06-22 | 0 | |
|
No longer subject to file | 2015-06-22 | 0 | |
|
No longer subject to file | 2015-06-22 | 0 | |
BAKER BROTHERS LIFE SCIENCES LP |
|
10,171,213 | 2015-06-22 | 0 |
|
10,170,173 | 2015-06-22 | 0 | |
|
No longer subject to file | 2015-06-22 | 0 | |
BOESS CARSTEN SVP, CHIEF FINANCIAL OFFICER |
|
No longer subject to file | 2015-06-22 | 0 |
|
0 | 2015-06-22 | 0 | |
|
No longer subject to file | 2015-06-22 | 0 | |
|
No longer subject to file | 2015-06-22 | 0 | |
HEBERLIG CHRIS SVP, FINANCE & BUSINESS OPS. |
|
No longer subject to file | 2015-06-22 | 0 |
PATEL SANJ K PRESIDENT & CEO |
|
No longer subject to file | 2015-06-22 | 0 |
QUINN ANTHONY EVP, CMO, & HEAD OF R&D |
|
No longer subject to file | 2015-06-22 | 0 |
WILLIAMS GLEN SVP, TECHNICAL OPERATIONS |
|
No longer subject to file | 2015-06-22 | 0 |
BAZEMORE ROBERT B CHIEF OPERATING OFFICER |
|
No longer subject to file | 2015-06-22 | 0 |
|
21,021,124 | 2015-06-19 | 0 | |
|
9,553,117 | 2015-01-07 | 0 | |
GOLDBERG MARK ALAN EVP, MEDICAL & REG. STRATEGY |
|
35,259 | 2014-09-19 | 0 |
BAKER BROS. INVESTMENTS II, L.P. BAKER BIOTECH FUND II (A), L.P. |
|
10,878,914 | 2014-06-20 | 0 |
|
10,264,682 | 2014-03-06 | 0 | |
SECOR ALICIA SVP, CHIEF OPERATING OFFICER |
|
50,000 | 2013-09-19 | 0 |
|
0 | 2013-07-01 | 0 | |
GLYNN MICHAEL SVP, GLOBAL COMMERCIAL OPS. |
|
40,000 | 2013-06-06 | 0 |
|
5,077,676 | 2012-07-13 | 0 | |
|
143,462 | 2012-07-13 | 0 | |
|
100,490 | 2012-07-13 | 0 | |
|
55,479 | 2012-07-13 | 0 | |
|
165,213 | 2012-07-13 | 0 | |
|
206,800 | 2012-07-13 | 0 | |
|
135,739 | 2012-07-13 | 0 | |
|
1,736,065 | 2012-07-13 | 0 | |
|
399,019 | 2012-07-12 | 0 | |
GRINSTEAD ERIC SVP, COMMERCIAL OPERATIONS |
|
0 | 2012-06-27 | 0 |
|
No longer subject to file | 2012-06-26 | 0 | |
|
0 | 2012-04-12 | 0 | |
|
1,736,065 | 2012-01-05 | 0 | |
|
5,077,676 | 2012-01-05 | 0 | |
|
135,739 | 2012-01-05 | 0 | |
|
0 | 2011-12-20 | 0 | |
|
576,463 | 2011-11-02 | 0 | |
|
597,217 | 2011-11-02 | 0 | |
|
144,082 | 2011-11-02 | 0 | |
|
220,692 | 2011-11-02 | 0 | |
|
206,800 | 2011-11-02 | 0 | |
|
No longer subject to file | 2011-11-02 | 0 | |
THOMAS JAMES R CHIEF FINANCIAL OFFICER |
|
0 | 2010-11-23 | 0 |
MATTINGLY MARTIN A CHIEF EXECUTIVE OFFICER |
|
0 | 2010-09-22 | 0 |
GRAHAM ANDREW L CHIEF FINANCIAL OFFICER |
|
0 | 2010-09-22 | 0 |
ALRUTZ MICHAEL A GENERAL COUNSEL |
|
0 | 2010-09-22 | 0 |
|
No longer subject to file | 2009-10-08 | 0 | |
HEALTHCOR HYBRID OFFSHORE HEALTHCOR OFFSHORE, LTD. |
|
0 | 2009-07-23 | 0 |
HEALTHCOR HYBRID OFFSHORE GP, LLC |
|
0 | 2009-07-21 | 0 |
HEALTHCOR HYBRID OFFSHORE GP, LLC |
|
0 | 2009-01-27 | 0 |
|
No longer subject to file | 2008-12-15 | 0 | |
OHMSTEDE CAROL |
|
0 | 2008-04-01 | 0 |
HEALTHCOR OFFSHORE, LTD. HEALTHCOR HYBRID OFFSHORE HEALTHCOR STRATEGIC, LLC |
|
3,950,000 | 2007-10-01 | 0 |
|
2,510,081 | 2007-08-20 | 0 | |
HEALTHCOR OFFSHORE, LTD. HEALTHCOR HYBRID OFFSHORE |
|
3,339,190 | 2007-08-13 | 0 |
RATTO DANIEL CHIEF FINANCIAL OFFICER |
|
0 | 2007-07-27 | 0 |
BOLOGNESI DANI P |
|
50,000 | 2007-07-15 | 0 |
HILL E LAWRENCE JR PRESIDENT AND COO |
|
0 | 2007-03-15 | 0 |
BONCZEK ROBERT R CFO AND GENERAL COUNSEL |
|
52,802 | 2007-02-28 | 0 |
LIPTON JEFFREY M |
|
20,000 | 2006-08-09 | 0 |
|
15,000 | 2006-08-09 | 0 | |
CROUT J RICHARD |
|
12,500 | 2006-08-09 | 0 |
SKOLSKY STEVEN D CHIEF EXECUTIVE OFFICER |
|
16,618 | 2006-04-03 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|